| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7325b07090c332a85a840ef48ce2e2d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_706210fbdbcad3ae159928d755cf910e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6c677f72141f7ec059fa79e713e691b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ed71d182ddb1cf04f7639af98935fa3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8d850f6b2008b524d24cdabda01088c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac4c80dfc3212a89193aaf6218568eb4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-91177
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-78 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6887 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 |
| filingDate |
2008-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24d65c01435e4019d7956e9921b93cfe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e428272ee214a41fab50d80012d9b21c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cbddc0d74f21f7b56449738faa4385c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f465c1e86fed50aaf44bce45d5cf9e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05b418b0019675e30cca3b332a22c66c |
| publicationDate |
2009-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009122387-A1 |
| titleOfInvention |
Method for the detection and prediction of obesity-related renal disease |
| abstract |
A method for the early identification and prediction of renal damage in a subject with obesity comprises contacting a urine sample from the subject with a capture molecule for a biomarker specific to a region of the kidney and which biomarker is released from said region when there is damage to said region, an elevated level of said biomarker relative to a normal level being indicative and predictive of renal damage. The biomarkers include αGST, πGST and Collagen IV. The method enables the detection of renal injury in obese patients who otherwise have been regarded as having normal renal function as measured by serum creatinine or estimated glomerular filtration rate, thereby facilitating early intervention in the treatment of such patients. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11585814-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10626464-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012012725-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10494675-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10934589-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10934588-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10961578-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012012704-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11001894-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11111537-B2 |
| priorityDate |
2008-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |